Barclays analyst Lauren Lieberman raised the firm’s price target on Procter & Gamble to $167 from $160 and keeps an Overweight rating on the shares. The company reported much better than anticipated results in fiscal Q3, including both an organic sales beat and significant inflection in gross margins, the analyst tells investors in a research note.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on PG:
- P&G Stock (NYSE:PG): Why I’m Not Buying Despite Strong Q3 Earnings
- Procter & Gamble price target raised to $165 from $160 at RBC Capital
- Procter & Gamble price target raised to $165 from $160 at Truist
- Procter & Gamble price target raised to $170 from $160 at Evercore ISI
- Procter & Gamble price target raised to $175 from $171 at Jefferies
